Language

Gadopentetate dimeglumine CAS NO：86050-77-3

Gadopentetate dimeglumine CAS NO：86050-77-3

Magnevist,AKA gadopentetate dimeglumine CAS NO：86050-77-3 is a contrast agent specifically designed for magnetic resonance imaging (MRI).

Categories：

Life Science Chemicals

Pharmaceutical Intermediates

Email：sale06@alfachem.cn

Inquiry

Chat Now

Product introduction

PRODUCT NAME	Gadopentetate dimeglumine
CAS NO	86050-77-3
EINECS NO	1308068-626-2
APPEARANCE	White solid
MF	C21H36GdN4O15-
STORAGE	2-8°C
DELIVERY	2-3DAYS
PACKAGE	According client's request

Description of Gadopentetate dimeglumine CAS NO：86050-77-3

Gadopentetate dimeglumine CAS NO：86050-77-3 is a gadolinium-based contrast agent that is used in angiography. It is also used to diagnose and visualize cancers, such as bladder cancer. Gadopentetate dimeglumine enhances the quality of images obtained from magnetic resonance imaging (MRI) by increasing the visibility of certain tissues or organs, such as the kidneys and bladder. It has been shown to be well tolerated with few adverse effects in clinical studies. Gadopentetate dimeglumine does not cause any significant changes in renal function or glomerular filtration rate.

Applications of Gadopentetate dimeglumine CAS NO：86050-77-3

Enhancing Specificity and Efficiency: A major focus of future research on Magnevist is directed towards enhancing its specificity and efficiency, particularly in targeted molecular imaging. This is particularly relevant in the field of oncology, where precision in imaging is crucial for the detection and treatment of cancers. Efforts are being made to improve the molecular structure of Magnevist to increase its binding affinity to specific tissues or pathological features in the body[“].

Development of New Formulations: Research is also being conducted to develop new formulations of Magnevist that could potentially reduce the issues related to gadolinium retention in tissues. These new formulations aim to provide safer alternatives that maintain the high-quality imaging capabilities of Magnevist while minimizing potential long-term retention in the body. Such developments could significantly impact the use of contrast agents in both clinical and research settings[“].

Applications in Nanotechnology: Another exciting area of research is the integration of Magnevist with nanotechnology. Studies are exploring the encapsulation of Magnevist within nanostructures, like dendrimers, to enhance its properties. This approach could lead to more effective and targeted delivery of the contrast agent, opening new possibilities in diagnostic imaging and possibly even in therapeutic applications[“].

Key words: